Measurement properties and clinical utility of the PASE-P for psoriatic arthritis screening in Brazilian patients with psoriasis

Read full text Summarise with VIRAT
Authors: José Alexandre Mendonça, ALEXANDRA MAURIEL DOS REIS, Ana Carolina Belini Bazán Arruda, Elaine Cristina Faria Abrahão Machado, Luciana Bertoldi Nucci
Cited by: 0
References: 24

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Approximately 15% of psoriasis (Ps) patients followed by a dermatologist have undiagnosed psoriatic arthritis (PsA). Questionnaires, such as the Psoriatic Arthritis Screening and Evaluation (PASE) tool, can be crucial in identifying these patients. Objective: Evaluate the performance of PASE-P (Portuguese version) as a screening tool for PsA in Ps patients. Methods: A retrospective study using cross-sectional data with Ps patients in a dermatology clinic. Instruments (PASE-P, PASI, DLQI and NAPSI) were applied to all participants. Results: A total of 63 patients were included, of whom 57.1% were men, with an average age of 53.7 years. After applying PASE-P, 33 patients (52.4%) had a CASPAR score of ≥3 and were classified as positive for PsA. Hypertension was the most prevalent comorbidity (33.3%). Median PASE-P scores were 24 (21 – 33) for the CASPAR ≥3 group, and 29 (23 – 36) for the CASPAR

Fields of Study & Subjects

Spondyloarthritis Studies and Treatments Psoriasis: Treatment and Pathogenesis Musculoskeletal pain and rehabilitation

Publication details

Journal / source
Brazilian Journal of Development
Volume
12
Issue
3
Pages
e86212–e86212
Publication date
18 March 2026
Language
EN